Bibliography

Abuabara K, et al. Prevalence of Atopic Eczema among patients seen in primary care: data from the Health Improvement Network. Ann Intern Med. 2019;170(5):354-365. doi:10.7326/M18-2246

Abuabara K, et al. The Long-Term Course of Atopic Dermatitis. Dermatol Clin. 2017;35(3):291-297

Adams RJ. Improving health outcomes with better patient understanding and education. Risk Manag Healthc Policy. 2010;3:61–72. doi:10.2147/RMHP.S7500

Adamson AS. The Economics Burden of Atopic Dermatitis. Adv Exp Med Biol. 2017;1027:79-92. doi:10.1007/978-3-319-64804-0_8

Adriens LFM. et. Al. Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systematic Treatment. Acta Derm Venereol. 2019;99(9):762-768. doi:

10.2340/00015555-3212

Akobeng AK, et al. Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation. EBioMedicine. 2015;2(9):1251–1256. doi:10.1016/j.ebiom.2015.08.011

Al-Dhubaibi MS. The effectiveness of alitretinoin for the treatment of chronic hand eczema: A metaanalysis.Int J Health Sci (Qassim). 2018;12(2):70–79

Allergy UK and Sanofi Genzyme. Seeing Red: Getting under the skin of adult severe eczema. 2017[Website]  Seeing_Red_Report_FINAL_25.04.17_original.pdf Accessed 22 Oct 2019

Arkwright P, et al. Management of difficult to treat AD. American Academy of Allergy, Asthma & Immunology. 2012;1(2):142-151. doi:10.1016/j.jaip.2012.09.002

Aubert H, et al. Non adherence and topical steroids. Ann Derm Ven. 2012;139(1):Suppl1:S7-12. doi:10.1016/S0151-9638(12)70102-3

Augustin M, et al. Translating the WHA resolution in a member state: towards a German programme on 'Destigmatization' for individuals with visible chronic skin diseases. J Eur Acad Dermatol Venereol. 2019 doi: 10.1111/jdv.15682

Bantz SK, et al. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.J Clin Cell Immunol. 2014;5(2):202. doi:10.4172/2155-9899.1000202

Barankin B , et al. Psychosocial effect of common skin diseases. Can Fam Physician. 2002;48:712–716

Barbarot S, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284-1293

Barbarot S, et al. The management of atopic dermatitis in children by dermatologists, paediatricians, general practitioners and allergologists: a national survey habits. Ann Dermatol Venereol 2005;132(1):283-95

Bashur RL, et al. The Empirical Foundations of Teledermatology: A Review of the Research Evidence Telemed J E Health. 2015;21(12):953–979. doi: 10.1089/tmj.2015.0146

Bass AM, et al. Interventions to Increase Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review Journal of clinical medicine 2015;4(2):231-42. doi:10.3390/jcm4020231

Bergmann KC, et al. Current status of allergy prevalence in Germany. Position paper of the Environmental Medicine Commission of the Robert Koch Institute. Allergo J Int. 2016;25:6–10

Bieber T. How to Define Atopic Dermatitis? Dermatol Clin. 2017;35(3):275-281

Bielory B, et al. Atopic dermatitis and keratoconjunctivitis. Immunol Allergy Clin North Am. 2010;30(3):323-36

Bradt J, et al. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database of Systematic Reviews. 2016(8). doi:10.1002/14651858.CD006911.pub3

Brown MH. A nurse-led clinic in chronic and allergic contact dermatitis. Br J Nurs. 2005;14(5):260-3

Brunner PM, et al. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. Journal of Investigative Dermatology. 2017;137(1):18 – 25; doi: 10.1016/j.jid.2016.08.022

Carter ZA, et al. Creation of an Internal Teledermatology Store-and-Forward System in an Existing Electronic Health Record. JAMA Dermatol. 2017;153(7):644–650

Cervero RM, et al. The Impact of CMA on Physician Performance and Patient Health Outcomes: An Updated Synthesis of Systematic Reviews. Journal of Continuing Education in the Health Professions. 2015;35(2):131-139

Cestari T, et al. The role of support groups in the treatment of atopic dermatitis. JAAD. 2017;52(3):P74-P74

Chalmers JR, et al. Effectiveness and cost-effectiveness of daily all-over-body application of emollient during the first year of life for preventing atopic eczema in high-risk children (The BEEP trial). Trials 2017;18(1):343. doi: 10.1186/s13063-017-2031-3

Charman CR, et al. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931-6

Charman CR, et al. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br J Dermatol. 2013;169(6):1326–1332

Chen JJ, et al. Atopic keratoconjunctivitis: A review. Journal of the American Academy of Dermatology 2014;70(3):569 – 575

Chiesa Fuxench ZC. Atopic Dermatitis: Disease Background and Risk Factors. Adv Exp Med Biol. 2017;1027:11-19. doi: 10.1007/978-3-319-64804-0_2

Chopra R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177(5):1316-1321. doi: 10.1111/bjd.15641

Choumane N, et al. A multicenter, prospective study evaluating the impact of the clinical pharmacistphysiciancounselling on warfarin therapy management in Lebanon. 2018;18(1):80. doi:10.1186/s12913-018-2874-7

Clausen ML, et al. Skin Barrier Dysfunction and the Atopic March. Curr Treat Options Allergy (2015)2:218-227. doi: 10.1007/s40521-015-0056-y

Cork MJ, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczemabefore and after explanation and demonstration of topical therapies by a specialist dermatology nurse.Br J Dermatol. 2003;149(3):582-9

Darlenski R, et al. Atopic dermatitis as a systemic disease. Clin Dermatol. 2014;32(3):409-13

De Souza YG, et al. Biobanking past, present and future: responsibilities and benefits. AIDS.2013;27(3):303–312. doi:10.1097/QAD.0b013e32835c1244

De Zoysa, P. Psychological interventions in dermatology. Indian J Dermatology. 2013;58(1):56-60.doi:10.4103/0019-5154.105312

Devonshire IM, et al. Risk-based learning games improve long-term retention of information among school pupils. PLoS One. 2014;9(7):e103640. doi:10.1371/journal.pone.0103640

Dhar S, et al. Food allergy in Atopic Dermatitis. Indian J Dermatology. 2016;61(6):645-648. doi:10.4103/0019-5154.193673

DiAnna-Kinder F, et al Satisfaction with Nurse Practitioners and Intent to Adhere to Plan. The Journal for Nurse Practitioners. 15(3):245 - 248.e1Dijk CE, et al. Compliance with referrals to medical specialist care: patient and general practice determinants: a cross-sectional study. BMC Fam Pract 2016;17:11

Drain PK, et al. Global health training and international clinical rotations during residency: current status, needs, and opportunities. Acad Med. 2009;84(3):320–325.doi:10.1097/ACM.0b013e3181970a37

Drucker A, et al. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association. Journal of Investigative Dermatology. 2017;137(1):26-30. doi: 10.1016/j.jid.2016.07.012

EASI for clinical signs: Harmonising Outcome Measures for Eczema (HOME); [Website]

http://www.homeforeczema.org/research/easi-for-clinical-signs.aspx Accessed 13 Mar 2019

EFA (2019). Atopic Eczema: Itching for life. Quality of Life and costs for people with severe atopic eczema in Europe

Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338–351. doi:10.1016/j.jaad.2013.10.010

Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis. Section 2. Management and treatment of atopic dermatitis with topical therapies J Am Acad Dermatol. 2014;71(1):116–132. doi: 10.1016/j.jaad.2014.03.023

Eiseman AS. The ocular manifestations of atopic dermatitis and rosacea. Curr Allergy Asthma Rep. 2006;6(4):292-8

Ellis RM, et al. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 2011;28:242-4

Embuldeniya G, et al. The experience and impact of chronic disease peer support interventions: a qualitative synthesis. Patient Educ Couns. 2013;92(1):3-12. doi:10.1016/j.pec.2013.02.002

Ersser SJ, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database of Systematic Reviews 2014;1. doi: 10.1002/14651858.CD004054.pub3

Fabbrocini G, et al. Treatment of Atopic Dermatitis with Biologic Drugs. Dermatol Ther (Heidelberg) 2018; 8(4):527-538. doi: 10.1007/s13555-018-0258-x

Fleischer DM, et al. Oral Food Challenges in Children with a Diagnosis of Food Allergy. Journal of Pediatrics; 2011;158(4):578-583

Flokstra-de Blok BM, et al. Development of an allergy management support system in primary care. J Asthma Allergy. 2017;10:57-65

Fortney JC, et al. VA community-based outpatient clinics: access and utilisation performance measures. Med Care. 2002;40(7):561-9. doi: 10.1097/01.MLR.0000017787.25488.CE

Frosch DL. Patient-Reported Outcomes as a Measure of Healthcare Quality. J Gen Intern Med. 2015;30(10):1383–1384. doi:10.1007/s11606-015-3476-2

Fyhrquist N, et al. The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper. Journal of Clinical and Translational Allergy 2019;9:3. doi:10.1186/s13601-019-0245-z

Garrity JA, et al. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984;19(1):21-4

Gerbens, L. et al. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries. Trials. 2017;18(1):87

GlobalSkin Position Paper: “Atopic Dermatitis: A Collective Global Voice for Improving Care”, February 2018

Gochnauer H, et al. The Psychosocial Impact of Atopic Dermatitis. Adv Exp Med Biol. 2017;1027:57- 69 doi: 10.1007/978-3-319-64804-0_6

Grillo M, et al. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol. 2006;23(5):428-36

Grossman SK, et al. Experiences with the first eczema school in the United States. Clin Dermatol. 2018;36(5):662-667

Grundmann S, et al. Chronic pruritus: clinics and treatment. Ann Dermatol. 2011;23(1): 1–11. doi: 10.5021/ad.2011.23.1.1

Hajar T, et al. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541-549.e2. doi: 10.1016/j.jaad.2014.11.024

Hajar T, et al. New and developing therapies for atopic dermatitis. An Bras Dermatol. 2018;93(1):104–107 doi:10.1590/abd1806-4841.20187682

Heratizadeh A. et al. Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial. J Allergy Clin Immunol. 2017;140(3):845-853. doi:10.1016/j.jaci.2017.01.029

HOME for eczema.org. EASI for clinical signs. [Website] http://www.homeforeczema.org/research/easi-for-clinical-signs.aspx Accessed 1 Mar 19

Huet F, et al. Characteristics of pruritus in relation to self-assessed severity of atopic dermatitis. ActaDV. 2019;99(3):279-283. doi: 10.2340/00015555-3053

International Alliance of Dermatology Patient Organizations. Atopic Dermatitis: A collective Global Voice for Improving Care [PDF] https://globalskin.org/images/Publications/AtopicDermatitis.pdf Accessed 1 Oct 2019

Jaspers JPC. Psychological interventions in atopic dermatitis. Psychologie & Gezondheid 2008;36(2):63-71

Johnson BB, et al. Treatment-resistant atopic dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol 2019;12:181–192. doi:10.2147/CCID.S163814

Kelly DV, et al. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013;146(4):218–226.doi:10.1177/1715163513492642

Kiiski V, et al. High serum total IgE predicts poor long-term outcome in atopic dermatitis. Acta Derm Venereol. 2015;95(8):943-7. doi: 10.2340/00015555-2126

Kowalska-Oledzka E, et al. Epidemiology of atopic dermatitis in Europe. Journal of Drug Assessment. 2019;8(11):126-128. doi: 10.1080/21556660.2019.1619570

Kownacki S. Skin diseases in primary care: what should GPs be doing? Br J Gen Pract. 2014;64(625):380–381. doi: 10.3399/bjgp14X680773

Larsson I, et al. A nurse-led rheumatology clinic versus rheumatologist-led clinic in monitoring of patients with chronic inflammatory arthritis undergoing biological therapy: a cost comparison study in a randomised controlled trial. BMC Musculoskelet Disord. 2015;16:354. doi:10.1186/s12891-015-0817-6

Launois R, et al. Importance of out‐of‐pocket costs for adult patients with atopic dermatitis in France. J Eur Acad Dermatol Venereol. 2019; 33(10):1921-1927. doi:10.1111/jdv.15581 le Roux E, et al. GPs’ experiences of diagnosing and managing childhood in primary care. British Journal of General Practice 2018;68(667):73-80. doi:10.3399/bjgp18X694529

LeBovidge J. Multidisciplinary interventions in the management of atopic dermatitis. The Journal of Allergy and Clinical Immunology. 2016;138(2):325-334. doi:10.1016/j.jaci.2016.04.003

Lee J, et al. A Comprehensive Review of the Treatment of Atopic Eczema. Allergy Asthma & Immunology Research. 2016;8(3):181-190. doi:10.4168/aair.2016.8.3.181Lee J, et al. A Comprehensive Review of the Treatment of Atopic Eczema. Allergy Asthma & Immunology Research. 2016;8(3):181-190. doi:10.4168/aair.2016.8.3.181

Leshem YA, et al. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172(5):1353-7. doi: 10.1111/bjd.13662

Leung DYM, et al. Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches. J Allergy Clin Immunol. 2014;134(4):769–779. doi: 10.1016/j.jaci.2014.08.008

Lewis V, et al. 10 Years Experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9:169 –180

Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab 2015;66(suppl 1):34-40

Lio P. Advances in atopic dermatitis raise bar for treatment. Dermatology Times, 2018;39(12)

Mancini AJ, et al. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol. 2008;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x

Martha S, et al. Progressive Muscle Relaxation. Journal of Human Behavior in the Social Environment 2006;13(3):51-66

Mastrorilli C, et al. Food allergy and atopic dermatitis: Prediction, progression, and prevention. Pediatr Allergy Immunol. 2017;28(8):831-840

McPherson T. Current Understanding in Pathogenesis of Atopic Dermatitis. Indian J Dermatol. 2016;61(6):649–655. doi:10.4103/0019-5154.193674

Mehta S. Patent Satisfaction reporting and its implications for patient care. AMA Journal of Ethics. 2015;17(7):616-21. doi: 10.1001/journalofethics.2015.17.7.ecas3-1507.

Mestrovic-Stefekov J, et al. Psychological Stress in Patients with Atopic Dermatitis. Acta Dermatovenerol Croat. 2018;26(4):297-303

Misery L, et al. The impact of atopic dermatitis on sexual health. J Eur Acad Dermatol Venereol. 2019;33(2):428-432. doi: 10.1111/jdv.15223.

Miyar ME, et al. An Atopic Dermatitis Management Algorithm for Primary Care Providers and Assessment of Its Usefulness as a Clinical Tool. Pediatr Dermatol. 2017;34(4):402-407. doi: 10.1111/pde.13157

Munidasa D, et al. What Should General Practice Trainees Learn about Atopic Eczema? J Clin Med. 2015;4(2):360–368. doi:10.3390/jcm4020360

Nahum Y, et al. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis:clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment. Br J Ophthalmol. 2019; doi: 10.1136/bjophthalmol-2019-315010

Napolitano M, et al. Adult atopic dermatitis: new and emerging therapies. Expt Review of Clin Pharm. 2018;11(9):867-878. doi: 10.1080/17512433.2018.1507734

Nelson EC, et al. Patient focused registries can improve health, care, and science. BMJ. 2016;354(8065) doi: 10.1136/bmj.i3319

Nicol NH, et al. The role of the nurse educator in managing atopic dermatitis. Immunol Allergy Clin North Am. 2010;30(3):369-83 

Noh S et al. Comparison of the psychological impacts of asymptomatic and symptomatic cutaneousdiseases: vitiligo and atopic dermatitis. Ann Dermatol. 2013;25(4):454-61. doi:10.5021/ad.2013.25.4.454

Numerical Rating Scale (NRS) [Website] http://www.pruritussymposium.de/numericalratingscale.html Accessed 14 Apr 2019

Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8-16 doi: 10.1159/000370220

Oosterhaven JAF, et al. Guideline for translation and national validation of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ). Contact Dermatitis. 2017;77(2):106-115

Paller A, et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin  Dermatol. 2018;19(6):821-838. doi: 10.1007/s40257-018-0383-4

Pesce G et al. Adult eczema in Italy: prevalence and associations with environmental factors. J Eur Acad Dermatol Venereol. 2015;29(6):1180-7. doi: 10.1111/jdv.12784

Petrova M, et al. Benefits and challenges of employing health care assistants in general practice: a qualitative study of GPs’ and practice nurses’ perspectives. Family Practice, 2010;27(3):303–311. doi: 10.1093/fampra/cmq011

Powell K, et al. GP and parent dissonance about the assessment and treatment of childhood eczema in primary care: a qualitative study. BMJ Open. 2018;8(2)

Randall S, et al. Impact of community based nurse-led clinics on patient outcomes, patient satisfaction, patient access and cost effectiveness: A systematic review. Int J of Nursing studies. 2017;73:24-33. doi: 10.1016/j.ijnurstu.2017.05.008

Reach G. Can we improve treatment adherence in patients with chronic disease? Bioethica Forum. 2014;7(3)

Reed B, et al. The burden of atopic dermatitis. Allergy Asthma Proc. 2018;39(6):406-410. doi: 10.2500/aap.2018.39.4175

Renert-Yuval, Yael et al. Systemic therapies in atopic dermatitis: The pipeline. Clinics in Dermatology. 2017;35(4):387-397. doi: 10.1016/j.clindermatol.2017.03.012

Ribeiro MKA, et al. Music therapy intervention in cardiac autonomic modulation, anxiety, and depression in mothers of preterms: randomized controlled trial. BMC Psychol. 2018;6(1):57. doi:10.1186/s40359-018-0271-y

Ring J, et al. Atopic eczema: burden of disease and individual suffering – results from a large EU study in adults. J Eur Acad Dermatol Venereol. 2019;33:1331-1340. doi: 10.1111/jdv.15634

Ring J, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) Part 1. JEADV. 2012;26(8):1045-1060. doi:10.1111/j.1468-3083.2012.04635.x

Roerdink EM, et al. Association of food allergy and atopic dermatitis exacerbations. Ann Allergy Asthma Immunol. 2016;116(4):334-8

Rouleau G, et al. Impacts of information and communication technologies on nursing care: anoverview of systematic reviews (protocol). Syst Rev. 2015;4:75. doi:10.1186/s13643015-0062-y

Sach TH, et al. Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review. Syst Rev. 2016;5:90. doi:10.1186/s13643-016-0262-0

Salvador S, et al. Atopic Dermatitis in Adults: A Diagnostic Challenge. J Investig Allergol Clin Immunol. 2017;27(2):78-88; (b) KPMG interviews

Schneider L, et al. Atopic dermatitis: A practice parameter update 2012. The Journal of Allergy and Clinical Immunology. 2013;131(2):295-299. doi: 10.1016/j.jaci.2012.12.672

Schofield JK, et al. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol 2011;165(5):1044–1050

Schopf T, et al. Impact of interactive web-based education with mobile and email-based support ofgeneral practitioners on treatment and referral patterns of patients with atopic dermatitis: randomized controlled trial. J Med Internet Res. 2012;5;14(6):e171

Schuttelaar ML, et al. Costs and costeffectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. Br J Dermatol. 2011;165(3):600-11

SCORing Atopic Dermatits (SCORAD) Calculator (0.9.0). [Website] http://scorad.corti.li/ Accessed 26 Feb 2019

Sibbald C, et al. Patient Burdern of Atopic Dermatitis. Dermatol Clin. 2017;35(3):303-316. doi: 10.1016/j.det.2017.02.004

Siegfried E, et al. Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications. J Clin Med. 2015;4(5):884-917. doi: 10.3390/jcm4050884

Silverberg JI, et al. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatology. 2018;3695):606-615. doi: 10.1016/j.clindermatol.2018.05.012

Silverberg JI. Health Care Utilization, Patient Costs, and Access to Care in US Adults With Eczema: A Population-Based Study. JAMA Dermatol. 2015;151(7):743–752. doi:10.1001/jamadermatol.2014.5432

Silvestre SJF, et al. Atopic Dermatitis in Adults: A Diagnostic Challenge. J Investig Allergol Clin Immunol 2017;27(2):78-88. doi:10.18176/jiaci.0138

Simpson E, et al. Association of Inadequately Controlled Disease and Disease Severity With Patient- Reported Disease Burden in Adults With Atopic Dermatitis. JAMA Dermatol. 2018;154(8):903–912. doi:10.1001/jamadermatol.2018.1572

Simpson E, et al. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. 2018;19(6):821-838. doi: 10.1007/s40257-018-0383-4

Simpson E. Comorbidity in Atopic Dermatitis. Curr Dermatol Rep. 2012;1(1):29–38. doi:10.1007/s13671-011-0003-5

Slattery MJ, et al. Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol. 2011;128(3):668–671. doi:10.1016/j.jaci.2011.05.003

Southerland JH et al. Interprofessional collaborative practice models in chronic disease management. 2016.

Spielmann S, et al. A review of multidisciplinary interventions in Atopic Dermatitis. Journal of Clinical medicine. 2015;4(5):1156-1170. doi: 10.3390/jcm4051156

Stabb D, et al. The double benefits of educational programmes for patients with eczema. BMJ. 2006;332. doi: 10.1136/bmj.38796.426736

Sullivan PB, et al. Parent satisfaction in a nurse led clinic compared with a paediatric gastroenterology clinic for the management of intractable, functional constipation. Arch Dis Child. 2006;91(6):499–501. doi:10.1136/adc.2005.087486

Taddeo D, et al. Adherence to treatment in adolescents. Paediatr Child Health. 2008;13(1):19–24

Tarn DM, et al. New prescriptions: how well do patients remember important information? Fam Med 2011;43(4):254–259

Tey HL, et al. Report on the 6th World Congress of Itch. J Invest Dermatol. 2012;132(4):1065–1067

Thijs JL, et al. Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis J Allergy Clin Immunol 2017;140(3):730-737. doi: 10.1016/j.jaci.2017.03.023

Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J. 2015;2:10 doi:10.3402/ecrj.v2.24642

Thyssen JP, et al. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77(2):280-28

Tonsaker T, et al. Health information on the Internet: gold mine or minefield? Can Fam Physician 2014;60(5):407–408

TREAT Registry Taskforce [Website] https://treat-registry-taskforce.org/ Accessed 2 Aug 2019 Tsai TF, et al. Burden of atopic dermatitis in Asia. Journ of Derm 2019;46. doi: 10.1111/1346-8138.15048

Tsakok T, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol. 2016;137(4):1071-1078

Vakharia P, et al. New therapies for atopic dermatitis: Additional treatment classes. JAAD. 2018;78(3):S76-S83

Validated Investigator Global Assessment For Atopic Dermatitis (vIGA-AD™) Scale [PDF]https://www.eczemacouncil.org/wp-content/uploads/2018/02/Validated-Investigator-Global-Assessment-Scale_vIGA-AD_2017.pdf Accessed 26 June 2019

van den Berg N, et al. AGnES: Supporting General Practitioners With Qualified Medical Practice Personnel. Dtsch Arztebl Int. 2009;106(1-2):3–9

van der Schaft J, et al. Is There an Additional Value of Inpatient Treatment for Patients with AtopicDermatitis? Acta Derm Venereol. 2016;96(6):797-801. doi: 10.2340/00015555-2410

Vermeulen FM, et al. TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on howand when to measure the core dataset for atopic eczema treatment research registries. Br J Dermatol. 2019;181(3):492-504. doi: 10.1111/bjd.17715

Weber MB, et al. Improvement of pruritus and quality of life of children with atopic dermatitis andtheir families after joining support groups. J Eur Acad Dermatol Venereol. 2008;22(8):992-7

Weidinger S, et al. Atopic Dermatitis. Lancet. 2016;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X

Weisshaar E, et al. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study(GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children. Acta Derm Venereol. 2008;88(3):234-9. doi:10.2340/00015555-0432

Werfel T, et al. The Diagnosis and Graded Therapy of Atopic Dermatitis. Dtsch Arztebl int. 2014;111(29-30): 509–520

Wilkinson K, et al. Development and validation of the Nonrestorative Sleep Scale (NRSS). J Clin Sleep Med 2013;9(9):929-937. doi: 10.5664/jcsm.2996

Wohlrab et al. 2013, Recommendations for detection of individual risk for comorbidities in patients with psoriasis. Arch Dermatol Res. 2013 Mar;305(2):91-8

Wollenberg A, et al. Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018;32(6):850-878

Wollenberg A. et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682

Wollenburg A, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I and part II: European Association of Dermatology and Venerology (EADV) World Health Organization. Global report on psoriasis. [PDF]

https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf?sequence=1&isAllowed=y Accessed 8 Aug 2019

Yarbrough KB, et al. The effects of treatment on itch in atopic dermatitis. Dermatol Ther. 2013;26(2):110-9. doi: 10.1111/dth.12032

Zuberbier T, et al. Patient perspectives on the management of atopic dermatitis. Journal of Allergy andClinical Immunology. 2006; 118(1):226-32